Suddenly there is no market for Progen's drug. Its failure in other conditions means this is now the end of the road. The sell-off has only just begun. Say goodnight, Gracie.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
